About a decade ago, Žiga Avsec, a PhD physics student at the time, unexpectedly delved into the world of genomics through a university machine learning module. His academic journey soon led him to a laboratory focused on rare diseases, where the mission was to decipher the intricate genetic mutations responsible for a peculiar mitochondrial disorder. It was akin to searching for a “needle in a haystack” as millions of potential genetic suspects resided within the complex DNA code. Particularly intriguing were the “missense variants” – single-letter genetic alterations that resulted in the creation of different amino acids within proteins. Since proteins constitute the fundamental building blocks of the human body, even subtle changes could trigger significant consequences.
The human genome harbors a staggering 71 million possible missense variants, with the average individual carrying over 9,000 of them. While most are benign, some are linked to genetic disorders like sickle cell anemia and cystic fibrosis, and even complex conditions like type 2 diabetes, potentially arising from a combination of subtle genetic alterations. Avsec was faced with a pressing question: “How can we pinpoint the genuinely hazardous ones?” Unfortunately, the response he encountered was disheartening: “In most cases, we simply can’t.”
Continue reading… “AlphaMissense: Revolutionizing Genetic Disease Research with DeepMind’s AI”